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ABSTRACT
Background: In studies on allergies in mouse models, IgE production is an essential parameter to be evalu-
ated. Here, we examine the effect of commercially available immunoreaction enhancer solutions and different
blocking reagents in enzyme-linked immunosorbent assay (ELISA) for total or antigen-specific murine IgE in or-
der to improve the assays.
Methods: Sera from mice immunized with recombinant house dust mite major allergens, Der f 1 and Der p 1,
were used for the assays. Total IgE was measured by sandwich ELISA using monoclonal antibodies against
murine IgE. Antigen-specific IgE was assayed using allergen-coated plates. Sensitivity or signal intensity in
ELISA was compared among conditions differing in the use of enhancer solutions, blocking reagents, or mono-
clonal antibodies, and incubation time.
Results: Use of enhancer solutions improved the sensitivity of ELISA for total IgE by approximately 30-fold of
that using a conventional buffer. A blocking reagent caused more unwanted enhancement of the background
signal in blank wells in ELISA for total IgE compared with another blocking reagent, however, improved signal
intensity in ELISA for antigen-specific ELISA without significant enhancement of the background signal. Opti-
mal assay conditions were determined.
Conclusions: Enhancer solutions are effective in improving ELISAs for total and antigen-specific murine IgE.
Selection of blocking reagents was important to decrease unwanted enhancement of background signals and
was effective in enhancing signals for positive samples. The ELISAs improved in this study are useful for the
study of allergies in mouse models.
KEY WORDS
allergen-specific IgE, blocking reagent, enzyme-linked immunosorbent assay, immunoreaction enhancer solu-
tion, mouse model, total IgE
INTRODUCTION
Immediate hypersensitivity is caused by the release
of mediators from mast cells and basophils activated
through aggregation of the high-affinity IgE receptor
(FcεRI) at the cell surface and allergen-specific IgE,
crosslinked by multivalent allergens such as those
derived from house dust mites, and pollen.1,2 Clini-
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cally, elevated levels of total or allergen-specific IgE
in serum are a major manifestation of allergic dis-
eases; therefore, in the study of allergies in mouse
models, IgE production is an important parameter for
evaluation.
Total IgE can be detected with a sandwich enzyme-
linked immunosorbent assay (ELISA) using a set of 2
anti-murine IgE monoclonal antibodies (mAbs).3 Al-
though weak signals for antigen-specific (Ag-specific)
murine IgE have been a problem, we have recently
reported on the enhancement of signal intensity in
ELISA for murine IgE specific, not only to ovalbumin,
but also recombinant forms of clinically relevant ma-
jor mite allergens, using commercially available im-
munoreaction enhancer solutions.4 Ag-specific IgE
ELISA simply modified by enhancer solutions has re-
markable advantages over conventional methods in
terms of signal intensity and handling, even over a
method with pretreatment of sera with protein G-
coupled beads.4-6 However, further improvement of
these assays for total IgE or Ag-specific IgE is neces-
sary because, for example, only small volumes of sera
can be collected intravenously from mice at intervals
without causing death, particularly in younger mice,
and the relatively long incubation time in modified
Ag-specific IgE ELISA, which takes 3 days from coat-
ing plates with allergens to absorbance measure-
ment,4 still needs to be shortened.
Here, we examine the effect of enhancer solutions
and different blocking reagents on ELISA for total or
Ag-specific murine IgE, to improve the sensitivity for
detection or the signal intensity, and to shorten the
time required for the assay.
METHODS
RECOMBINANT Der f 1 AND Der p 1
Recombinant mature forms of house dust mite major
group 1 allergens, Der f 1 and Der p 1, without (Der f
1-N53Q and Der p 1-N52Q) and with yeast-derived
hyperglycosylation (Der f 1-WT and Der p 1-WT),
were prepared as previously described.7-11 Der f 1-
N53Q (rDer f 1) and Der p 1-N52Q (rDer p 1) were
used for immunization after incubation with L-
cysteine.3,4,12 Since B-cell epitopes for recombinant
forms with and without hyperglycosylation are con-
sidered to be equivalent among natural Der f 1, rDer f
1, and Der f 1-WT and natural Der p 1, rDer p 1, and
Der p 1-WT,8,9 we used hyperglycosylated Der p 1-
WT and Der f 1-WT to detect Der p 1- and Der f 1-
specific Abs as alternatives to unglycosylated rDer p
1 and rDer f 1, respectively, the production of which
is much less than that of the hyperglycosylated forms
in yeast.11
IMMUNIZATION OF MICE
Six-to-8-week-old female CBAJ mice were purchased
from Charles River Japan, Inc. (Yokohama, Japan)
and immunized as previously described.3,4,12 Mice
were given 4 weekly intraperitoneal injections of 0.5
or 1 μg of rDer f 1 or 1, 2, or 2.5 μg of rDer p 1 ad-
sorbed on Alum (ImjectAlum; Pierce, Rockford, IL,
USA). Sera collected at 1 week after the last injection
were stored at −20℃ before assays. Sera used for the
experiment in Figures 4, 6 were collected after the
mice were challenged intranasally, twice with rDer p
1 (10 μghead) 2 months after the last intraperitoneal
injection.
IMMOBILIZATION OF MONOCLONAL ANTIBOD-
IES AND ALLERGENS AND BLOCKING
Anti-murine IgE monoclonal antibodies (mAbs) (2
μgml, 50 μlwell) or allergens (10 μgml, 50 μl
well) were diluted with phosphate-buffered saline
(PBS), and 96-well microtiter plates for ELISA (Max-
iSorp; Nunc, Rockilde, Denmark) were incubated
overnight with the allergen solutions at 4℃. After 1
or 2 washes with PBS containing 0.05% (vv) Tween
20 (PBST), the plates were incubated with BlockAce
(BA) (DS Pharma Biomedical Co. Ltd., Osaka, Japan)
diluted with pure water (14 dilution), or with Im-
munoBlock (IB) (DS Pharma Biomedical Co. Ltd.) di-
luted with pure water (15 dilution) for 1.5 hours at
37℃ or 3 hours at room temperature (200 μlwell).
After 2 washes with PBST, the plates were incubated
with diluted sera.
ELISA FOR TOTAL IgE
The total concentration of IgE in the sera was meas-
ured by sandwich ELISA using a combination of a
non-labeled anti-murine IgE mAb (clone R35―72; BD
Biosciences, San Jose, CA, USA) and a horseradish
peroxidase (HRP)-labeled anti-murine IgE mAb
(clone LO-ME-2; Technopharm Biotechnology, Paris,
France) or another non-labelled anti-murine IgE mAb
(clone LOME-3; Technopharm Biotechnology), and
HRP-labeled mAb (clone LOME-2) with murine mon-
oclonal IgE specific to TNP (purified mouse IgE iso-
type control, clone IgE-3; BD Biosciences) as the
standard. Volumes of 50 μl of standard IgE or sera di-
luted with Solution 1 of CanGetSignal (CGS1)
(Toyobo, Osaka, Japan), PBST with 10% (vv) BA
(PBST-BA), or PBST with 5% (vv) IB (PBST-IB)
were added to the wells on the plates, which were
coated with each of the anti-murine IgE mAbs and
blocked as described above. Serum dilution factors
were 200 or 1000. After incubation for 80 minutes at
37℃ and 3―5 washes with PBST, HRP-conjugated
anti-murine IgE mAb (clone LO-ME-2) diluted with
Solution 2 of CanGetSignal (CGS2) (Toyobo), PBST-
BA, or PBST-IB was added to the plates (50 μlwell).
After incubation for 80 minutes at 37℃ and 3―5
washes with PBST, the color was developed for 20
minutes using tetramethyl benzidine (BD-OptEIA kit;
BD Biosciences) (100 μlwell), and the reaction was
terminated by adding 2N sulfuric acid (50 μlwell).
Optical density was measured at 450 nm, from which
ELISAs for Ag-SpecificTotal Murine IgE
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Fig. 2 Efect of concentrations of capture and detection mAbs in total IgE ELISA. Anti-
murine IgE mAb, clone R35―72, was immobilized onto the plates at concentrations indi-
cated (A) or at 2 μg/ml (B). BlockAce (BA) or ImmunoBlock (IB) was used for blocking. Di-
lution factors for detection mAb were 4000 (A) or as indicated (B). Data show the means± 
ranges of duplicated wels. Absorbance of the air blank is set at zero.
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570 nm was subtracted. Detailed conditions of the as-
say are described in the figure legends.
ELISA FOR Ag-specific IgE
Volumes of 50 μl of sera diluted with CGS1, PBST-
BA, or PBST-IB were added to the wells on the
plates, which were coated with allergens and blocked
as described above. After incubation and 3―5 washes
with PBST, HRP-conjugated anti-murine IgE mAb
(clone LO-ME-2) diluted with CGS2, PBST-BA, or
PBST-IB was added to the plates (50 μlwell). After
incubation and 3―5 washes with PBST, color was de-
veloped and the reaction was terminated in a manner
similar to the total IgE ELISA described above. Opti-
cal density at 450 nm, from which 570 nm was sub-
tracted, was used as the signal for Ag-specific IgE.
Detailed conditions of the assay are described in the
figure legends.
REMOVAL OF IgE FROM SERUM
Anti-IgE beads were prepared by covalent coupling of
anti-murine IgE mAb (clone R35―72) to CNBr-
activated Sepharose 4B beads and used to remove
IgE from sera, as described previously.4 Sera treated
with control beads, with no protein coupling, were
also prepared.
RESULTS
EFFECT OF BLOCKING REAGENTS AND EN-
HANCER SOLUTIONS IN TOTAL IgE ELISA
The effect of blocking reagents (BA and IB) and en-
hancer solutions (CGS1 and CGS2) in sandwich
ELISA for murine IgE was examined (Fig. 1, 2). The
use of CGS1 to dilute standard IgE did not affect the
detection sensitivity and background absorbance in
blank wells (Fig. 1A, B, triangles). CGS2 to dilute the
detection mAb improved detection sensitivity by ap-
proximately 30-fold but increased the background ab-
sorbance in blank wells (Fig. 1A, B, circles). The in-
crease in background absorbance was higher when
using IB for blocking (Fig. 1A, B, lower panels) than
BA (Fig. 1A, B, upper panels). Similar effects were
observed when using both the 2 capture mAbs, R35―
72 (Fig. 1A) and LOME-3 (Fig. 1B). The dose-
ELISAs for Ag-SpecificTotal Murine IgE
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Fig. 3 Comparison of IgE concentrations determined by total IgE ELISAs using conventional bufers and 
enhancer solutions. A: Standard curves. Anti-murine IgE mAb, clone R35―72, was immobilized onto the 
plates at 2 μg/ml. BlockAce (BA) was used for blocking. Dilution factor for detection mAb was 4000. Data 
show the means±ranges of duplicated wels. Absorbance of blank wels with no addition of standard IgE 
is set at zero. B: IgE concentration determined by using conventional bufer (PBST-BA) or enhancer solu-
tions (CGS). Individual sera from 15 mice intraperitonealy immunized with rDer f 1 (0.5 or 1 μg/head) or 
rDer p 1 (1 or 2 μg/head), respectively, were used for the assay.
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dependent curves in the 2 capture mAbs almost com-
pletely overlapped when using BA for blocking (Fig.
1C). The results shown in Figure 1 indicate that us-
ing CGS2 to dilute the detection mAb is strikingly ef-
fective, that BA for blocking exhibits lower back-
ground absorbance in blank wells than blocking re-
agent IB, and that the 2 capture mAbs have similar
potential.
Concentrations of capture and detection mAbs
when using CGS1 to dilute standard IgE, and CGS2
to dilute detection mAb, were examined (Fig. 2). The
background absorbance in blank wells to which no
standard IgE was added (Fig. 2, IgE: 0 ngml) de-
creased, corresponding to the decrease in the con-
centrations of capture (Fig. 2A) and detection mAbs
(Fig. 2B) particularly when using IB for blocking
(Fig. 2, lower panels). The results shown in Figure 2
suggest that the increase in background absorbance
when using CGS2 to dilute detection mAb (Fig. 1A,
B) could be due to the enhancement of direct binding
of detection mAb to immobilized capture mAb.
COMPARISON OF IgE CONCENTRATIONS DE-
TERMINED BY TOTAL IgE ELISAs USING CON-
VENTIONAL BUFFERS AND ENHANCER SOLU-
TIONS
According to the results shown in Figures 1, 2, we
considered the following conditions for total IgE
ELISA to be the optimum: 2 μgml for the concentra-
tion of capture mAb R35―72, BA for blocking, CGS1
for dilution of standard IgE and sera, and CGS2 for di-
lution (14000 dilution) of the capture mAb. We ex-
amined whether these conditions were suitable to
measure total IgE in mouse sera by comparing with
conventional assay conditions previously described3
(Fig. 3). Detection sensitivity improved by approxi-
mately 30-fold when using the enhancer solutions
(Fig. 3A). The determined IgE concentrations in 30
individual sera from mice immunized with rDer f 1 or
rDer p1 were almost identical for both conventional
(Fig. 3B, PBST-BA) and improved assay conditions
(Fig. 3B, CGS). The results indicate that the im-
proved assay condition is suitable for measurement of
total IgE.
EFFECT OF BLOCKING REAGENTS AND BUFF-
ERS ON DILUTION OF SERA AND DETECTION
mAb IN Ag-specific IgE ELISA
The effect of blocking reagents and enhancer solu-
tions in ELISA for murine Ag-specific IgE in pooled
serum from mice immunized with rDer p 1, used in
our previous study4 (Fig. 4), or from mice immunized
with rDer f 1 (Fig. 5), was examined. Previously, we
reported that the use of enhancer solutions, CGS1
and CGS2, significantly enhanced the signal intensity
in Ag-specific IgE ELISA, when BA was used for
blocking.4 When using CGS2 to dilute the detection
mAb (Fig. 4), signal intensity was increased when us-
Takai T et al.
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Fig. 4 Efect of blocking reagents and enhancer solutions for serum dilution in Ag-specific IgE ELISA and confirma-
tion of IgE isotype specificity. Der p 1-WT was immobilized onto the plates at 10 μg/ml. BlockAce (BA) (A and C) or 
ImmunoBlock (IB) (B and D) was used for blocking. Sera were anti-rDer p 1 pooled serum from mice intraperitonealy 
immunized with rDer p 1 (2.5 μg/head) and then intranasaly administrated with rDer p 1 (10 μg/head) (rDer p 1) and 
those treated with anti-IgE beads (Anti-IgE) or control beads (Cont.), and diluted with PBST-BA (A), PBST-IB (B), or 
CGS1 (C and D). Incubation with sera was for 15 hours at 4℃. Incubation with detection mAb diluted with CGS2 was 
for 5 hours at room temperature. Dilution factor for detection mAb was 2000. Data show the values for single wels. 
Absorbance of triplicate blank wels with no addition of sera (means±SD: 0.143±0.006 in A, 0.255±0.002 in B, 
0.233±0.008 in C, and 0.344±0.001 in D) is set at zero.
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ing IB for blocking (Fig. 4B), CGS1 for serum dilu-
tion (Fig. 4C), or a combination of both (Fig. 4D).
Compared with previously published data,4 CGS2 for
dilution of detection mAb was effective to enhance
the signal intensity even when using BA for blocking
and PBST-BA for serum dilution (Fig. 4A). Isotype
specificity for IgE was confirmed using a pooled se-
rum treated with anti-IgE beads (Fig. 4, Anti-IgE).
When using IB for blocking (Fig. 5), CGS2 used to
dilute detection mAb was extremely effective in in-
creasing signal intensity (Fig. 5C, D). However, com-
pared with the marked enhancement observed by us-
ing CGS2 to dilute the capture mAb, CGS1 for serum
dilution was not so effective.
EFFECT OF BLOCKING REAGENTS AND INCU-
BATION TIME IN Ag-specific IgE ELISA USING
ENHANCER SOLUTIONS
As IB for blocking was more effective for signal en-
hancement than BA (Fig. 4, 5), we further examined
the effect of IB to shorten the incubation time (Fig. 6,
7). Using the anti-Der p 1 pooled serum from Figure
4, the effect of IB (Fig. 6B, C) in 2 incubation sched-
ules was compared with that of BA in a previous con-
dition (Fig. 6A). When following the same schedule
for the duration of incubation (overnight for serum
and 5 hours for detection mAb), blocking with IB
(Fig. 6B) enhanced signal intensity more than block-
ing with BA (Fig. 6A), although nonspecific binding
of IgE to the plate was also enhanced by adding anti-
TNP IgE (10 μgml and 100 μgml) to the pooled se-
rum from vehicle-treated mice (Fig. 6B, Vehicle).
Blocking with IB under a shortened incubation
schedule (2 hours for serum and 2 hours for detec-
tion mAb) (Fig. 6C), showed similar signal intensity
to blocking with BA under the longer schedule (Fig.
6A) without enhancement of nonspecific IgE binding
to the plate.
Using 35 individual sera from mice immunized
with rDer f 1 (Fig. 7A) or rDer p 1 (Fig. 7B), we ex-
amined whether the conditions using IB for blocking
are suitable for detection of Ag-specific IgE by com-
ELISAs for Ag-SpecificTotal Murine IgE
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Fig. 5 Efect of enhancer solutions in Ag-specific IgE ELISA. Der f 1-WT was immobilized onto the plates at 
10 μg/ml. ImmunoBlock (IB) was used for blocking. Sera were anti-rDer f 1 pooled serum from mice intraperi-
tonealy immunized with rDer f 1 (1 μg/head) (rDer f 1) and control pooled serum (Vehicle), and diluted with 
PBST-IB (A and C) or CGS1 (B and D). Incubation with the pooled sera was for 15 hours at 4℃. Incubation 
with detection mAb diluted with PBST-IB (A and B) or CGS2 (C and D) (1/2000 dilution) was for 5 hours at 
room temperature. Data show the means±SD of triplicate wels. Absorbance of triplicate blank wels with no 
addition of sera (means±SD: 0.054±0.007 in A, 0.049±0.006 in B, 0.255±0.031 in C, and 0.264±0.023 
in D) is set at zero.
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paring them with assay conditions using BA. Overall,
the order of signals for the sera was similar among
the conditions tested (Fig. 7). Signal intensity was at
its highest when blocking with IB, a 15-hour incuba-
tion with sera, and a 5-hour incubation with detection
mAb. In addition, 2 other conditions (blocking with
BA, 15-hour incubation with sera, and 5-hour incuba-
tion with detection mAb; and blocking with IB, 15-
hour incubation with sera, and 2-hour incubation with
detection mAb) showed a similar signal intensity, and
the shortest condition (blocking with IB, 2-hour incu-
bation with sera, and 2-hour incubation with detection
mAb) showed a similar or slightly less signal inten-
sity. The results indicate that the assay conditions us-
ing IB for blocking are most suited to detect Ag-
specific IgE.
DOSE-DEPENDENCY OF ABSORBANCE WITH
Ag-concentration IN THE Ag-immobilization
STEP
Using the anti-Der p 1 pooled serum from Figures 4,
6, we examined the dose-dependency of absorbance
with Ag-concentration in the Ag-immobilization step
(Fig. 8). Absorbance increased in a dose-dependent
manner in the short assay condition (blocking with
IB, 2-hour incubation with sera, and 2-hour incuba-
tion with detection mAb) using the enhancer solu-
tions (Fig. 8, solid dots with solid lines). Without the
use of enhancer solutions, a dose-dependent increase
of absorbance was very small (Fig. 8A, triangles).
Pooled serum from vehicle-treated mice (Fig. 8B, Ve-
hicle, circles with broken lines) showed similar ab-
sorbance levels to that when no additions of serum
were made (Fig. 8B, No serum).
DISCUSSION
When studying allergies in mouse models, IgE pro-
duction is an important parameter for evaluation. In
this study, we examined the effect of enhancer solu-
tions and different blocking reagents on ELISA for to-
tal or Ag-specific murine IgE, in order to improve the
detection sensitivity or signal intensity or to shorten
the time of the assay. The application of enhancer so-
lutions was effective in improving ELISAs for total
(Fig. 1―3)and Ag-specific murine IgE (Fig. 4―8). Se-
lection of blocking reagents was important to de-
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Fig. 6 Efect of blocking reagents, enhancer solutions, and incubation time in Ag-specific IgE ELISA and evaluation of nonspe-
cific binding of IgE to the plate. Der p 1-WT was immobilized onto the plates at 10 μg/ml. BlockAce (BA) (A) or ImmunoBlock 
(IB) (B and C) was used for blocking. Sera were anti-rDer p 1 pooled serum from Fig. 4 and control pooled serum (Vehicle), and 
diluted with CGS1. Pooled serum of the vehicle was added to 1, 10, or 100 μg of monoclonal IgE specific to TNP/ml of serum. 
Incubation with the pooled sera was for 15 hours at 4℃ (A and B) or 2 hours at 37℃ (C). Incubation with detection mAb diluted 
with CGS2 (1/2000 dilution) was for 5 hours at room temperature (A and B) or 2 hours at 37℃ (C). Data show the means±SD 
of triplicate wels. Absorbance of blank wels with no addition of sera in each assay condition is set at zero.
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Fig. 7 Comparison of signal intensity among diferent assay conditions in Ag-specific IgE ELISA. Der f 1-WT (A) or 
Der p 1-WT (B) was immobilized onto the plates at 10 μg/ml. BlockAce (BA) or ImmunoBlock (IB) was used for block-
ing as indicated. Individual sera from 18 or 17 mice intraperitonealy immunized with rDer f 1 (0.5 or 1 μg/head) or 
rDer p 1 (1 or 2 μg/head), respectively, diluted with CGS1 (1/200 dilution) were used. Incubation with the sera was for 
15 hours at 4℃ or 2 hours at 37℃. Incubation with detection mAb diluted with CGS2 (1/2000 dilution) was for 5 hours 
at room temperature or 2 hours at 37℃. Absorbance of blank wels with no addition of sera in each assay condition 
is set at zero.
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Fig. 8 Dose dependency of absorbance with Ag-concentration in the Ag-immobilization 
step. Der p 1-WT was immobilized onto the plates at 1.25―80 μg/ml. ImmunoBlock (IB) was 
used for blocking. A: Anti-rDer p 1 pooled serum from Figure 4, 6 was diluted with CGS1 or 
PBST-IB (1/200 dilution). Incubation with the sera was for 2 hours at 37℃. Incubation with de-
tection mAb diluted with CGS2 (1/4000 dilution) or PBST-IB (1/2000 dilution) was for 2 hours 
at 37℃. B: Sera were the anti-rDer p 1 pooled serum (rDer p 1) and control pooled serum (Ve-
hicle), and diluted with CGS1 (1/200, 1/1000, or 1/5000 dilution). No serum: CGS1 with no ad-
dition of serum was added to wels. Data show the values for single wels in A and the means
± ranges of duplicated wels in B. Diferently from Figure 4― 7, absorbance of air blank is 
set at zero.
Blocking:
Serum:
Detection Ab:
IB
CGS1 (2 h)
CGS2 (2 h)
Blocking:
Serum:
Detection Ab:
IB
CGS1 (2 h)
CGS2 (2 h)
IB
PBST-IB (2 h)
PBST-IB (2 h)
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
1.0
0.8
0.6
0.4
0.2
0.0
0.4
0.2
0.0
0 10 20 30 40 50
0.0 2.5 5.0 7.5 10.0 0.0 2.5 5.0 7.5 10.0
60 70 80
A
bs
or
ba
nc
e
A
bs
or
ba
nc
e
A Dilution factor (serum): 200
lmmunogen: rDer p 1
B
Dilution factor (serum): 
200
Dilution factor (serum): 
1000 0.4
0.2
0.0
0.0 2.5 5.0 7.5 10.0
Dilution factor (serum): 
5000 0.4
0.2
0.0
0.0 2.5 5.0 7.5 10.0
No serum
lmmunogen:
rDer p 1
Vehicle
lmmobilized rDer p 1 (μg/ml)
lmmobilized rDer p 1 (μg/ml)
crease unwanted enhancement of the background
signal in total IgE ELISA (Fig. 1, 2) and was effective
in enhancing signals for positive samples in Ag-
specific IgE ELISA (Fig. 4, 6, 7). The sensitivity of to-
tal IgE ELISA was improved to approximately 30-fold
with enhancer solutions (Fig. 1A, B, 3A). Previously,
we reported on signal enhancement in Ag-specific
IgE ELISA using enhancer solutions, yet the assay
took 3 days from coating plates with allergens to ab-
sorbance measurement.4 However, by combining
with another blocking reagent, IB, in the present
study, we achieved similar signal intensity levels even
under assay conditions with a shorter incubation time
(Fig. 6―8).
In total IgE ELISA, sensitivity was improved by ap-
proximately 30-fold compared with our previous as-
say4 (Fig. 1A, B, 3A). The use of CGS2 to dilute the
detection mAb critically contributes to improvement,
and BA for blocking shows lower background absor-
bance in blank wells than another blocking reagent
IB (Fig. 1). The increase of background absorbance
with CGS2 to dilute detection mAb (Fig. 1A, B) could
be due to enhanced binding of the detection mAb to
the immobilized capture mAb (Fig. 2). The sensitivity
improvement in the present study using HRP-labeled
anti-murine IgE mAb for detection is equivalent to us-
ing a combination of biotinylated anti-murine IgE
mAb and streptavidinalkaline phosphatase conjugate
for detection.13
Although weak signals for Ag-specific murine IgE
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have been a problem, we recently reported the en-
hancement of signal intensity in ELISA for murine
IgE specific not only to ovalbumin but also recombi-
nant forms of clinically relevant major mite allergens
using enhancer solutions.4 CGS2 to dilute detection
mAb was strikingly effective in increasing signal in-
tensity (Fig. 5). Compared with the marked enhance-
ment using CGS2 to dilute detection mAb, the effects
observed using CGS1 for serum dilution were limited
(Fig. 4, 5). A combination of enhancer solutions and
another blocking reagent, IB, achieved equivalent
signal intensity even under assay conditions with a
shorter incubation time (Fig. 6, 7). Results using se-
rum depleted of IgE (Fig. 4) or supplemented with
IgE (Fig. 6) support isotype specificity to IgE and in-
dicate that the nonspecific binding of IgE to the plate
is low under the conditions in Figure 6A, C, and that
titration is useful for the appropriate evaluation of Ag-
specific IgE, even at higher IgE concentrations, un-
der the conditions shown in Figure 6B. Blocking with
IB under a shortened incubation schedule (2 hours
for serum and 2 hours for detection mAb) (Fig. 6C)
showed a similar signal intensity to blocking with BA
under a longer incubation schedule (Fig. 6A) without
significant enhancement of nonspecific IgE binding
to the plate.
Dose dependency of absorbance with Ag-
concentration in the Ag-immobilization step (Fig. 8)
along with Figure 6C supports the fact that the bind-
ing of IgE to the plates is Ag-specific. Unwanted di-
rect binding of the detection Ab to Ag proteins immo-
bilized onto the plates differs among Ag proteins (un-
published data). In the present study, we showed
data using sera from CBAJ mice because the strain
indicated a higher total and Ag-specific IgE response
even at a relatively low dose.4 The use of enhancer
solutions was also effective for signal enhancement in
Ag-specific IgE within sera from BALBc and
C57BL6 mice (Ref. 4, in addition to unpublished
data) . We recommend optimization of Ag-
concentration in the immobilization process, incuba-
tion time, and blocking reagents according to the Ags
and Ag-specific IgE titers of sera.
The results using individual sera from mice immu-
nized with recombinant house dust mite major aller-
gens before and after improvement indicate that the
improved assay conditions are suitable for measure-
ment of total IgE (Fig. 3) or Ag-specific IgE (Fig. 7).
Since only small amounts of sera can be collected in-
travenously from mice at intervals without causing
death, particularly in younger mice, improvement in
detection sensitivity and signal enhancement, even
with extensive serum dilution, is beneficial. The IgE
response specific to clinically relevant allergens other
than ovalbumin, which has been frequently used in
animal models of allergies, is an important issue to in-
vestigate because recent studies have suggested that
allergen sources have specific properties to promote
Th2 sensitization to IgE production or exacerbation
processes.3,6,12,14-30 Ag-specific IgE ELISA with en-
hanced signal intensity for clinically relevant major al-
lergens4 (Fig. 4―8) is a strong tool for addressing this
issue. The conditions recommended in this report are
useful for studying allergies using mouse models.
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